Released Title Price Sensitive Download Types
2024-01-04 09:13:00 First Patient Dosed in Urothelial Cancer INSIGHT-005 Trial 0 https://app.sharelinktechnologies.com/announcement/asx/0681f63cab07a4c3339c60fc213712bf
    Progress Report
2024-01-08 08:22:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/8eab8e68671a37661d3c8cedf1940b80
    Company Presentation
2024-01-15 17:03:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/dddc7997dcc4a85236bde28e098ab7fa
    Change in substantial holding
2024-01-30 08:32:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/f974b1158e6e9fe43fab9a64b21cf036
    Commitments Test Entity - Second Quarter Report
    Commitments Test Entity - Second Quarter Activity Report
2024-01-31 19:31:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/49b6c543ff2139acc7d4c3e029ab5a84
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2024-02-14 09:12:00 Appointment of Non-Executive Director 0 https://app.sharelinktechnologies.com/announcement/asx/c5bf709600c2755d526d0876d9d4cced
    Director Appointment/Resignation
2024-02-14 10:20:00 Appendix 3X - Anne Anderson 0 https://app.sharelinktechnologies.com/announcement/asx/b88c65f565f3f9ed4d4bbde429e16571
    Initial Director's Interest Notice
2024-02-14 13:05:00 Ceasing to be a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/8c8900ee77c1a7169f41d4ad4edf0845
    Ceasing to be a substantial holder
2024-02-15 16:45:00 Becoming a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/76ab17c47eabb7c014e14b4f46740c48
    Becoming a substantial holder
2024-02-20 16:46:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/08a43b9d275c2c087e56e061fead178c
    Change in substantial holding
2024-02-21 16:55:00 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/1dbd4ec3cc065acdb862bfcfcfeb230e
    Periodic Reports - Other
    Letter to Shareholders
2024-02-22 18:14:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/a6b56aa2a36b5858d438262606935a3f
    Change in substantial holding
2024-02-26 16:47:00 Becoming a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/0e15d7a4803eb2318752c4ec8deb3e5e
    Becoming a substantial holder
2024-02-28 09:39:00 Half Yearly Report and Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/923355c17b6516dd53465405abacbd63
    Half Yearly Report
    Half Year Audit Review
    Half Year Directors' Statement
    Half Year Accounts
    Half Year Directors' Report
2024-03-05 12:34:00 First Clinical Data announced from 90mg Dosing of Efti 1 https://app.sharelinktechnologies.com/announcement/asx/e7eb8029b775cc6ef3029596453570a0
    Progress Report
2024-03-08 16:27:00 Ceasing to be a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/5072a2741ccc5e921edc61a6523422b6
    Ceasing to be a substantial holder
2024-04-11 18:30:00 Ceasing to be a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/4a319c100c2afa915652dcdaae237244
    Ceasing to be a substantial holder
2024-04-17 09:10:00 Positive Feedback received from Spanish Medicines Agency 0 https://app.sharelinktechnologies.com/announcement/asx/d43894001dafa767ff0f66e980d8cca2
    Progress Report
2024-04-18 09:36:00 CHDR to conduct first-in-human phase 1 trial of IMP761 1 https://app.sharelinktechnologies.com/announcement/asx/a98578c19ebb71f188e1e45a50925906
    Progress Report
2024-04-24 08:40:00 Positive preliminary topline results from TACTI-003 Cohort B 1 https://app.sharelinktechnologies.com/announcement/asx/b2451fe39828d6a3bc21477964b57aff
    Progress Report
2024-04-29 08:18:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/35d064011d471f1cca85165ef4aaee1a
    Commitments Test Entity - Third Quarter Report
    Commitments Test Entity - Third Quarter Activity Report
2024-05-02 09:29:00 Positive initial data in phase 2 Soft Tissue Sarcoma trial 1 https://app.sharelinktechnologies.com/announcement/asx/24f49f8204f4760123e9087c622c4511
    Progress Report
2024-05-15 18:01:00 AIPAC-003 safety lead-in data presented at ESMO Breast 2024 1 https://app.sharelinktechnologies.com/announcement/asx/9eb3278d9e3ac507acecc898dd73301e
    Progress Report
2024-06-03 08:51:00 Trading Halt 1 https://app.sharelinktechnologies.com/announcement/asx/43f1ca7e5e47afbb3884635083c1902e
    Trading Halt
2024-06-03 09:14:00 A$100 million fully underwritten equity raising 1 https://app.sharelinktechnologies.com/announcement/asx/26136f6e9e3d0db0120f09828ba9abb9
    Placement
    Non-Renounceable Issue
2024-06-03 09:19:00 Immutep Capital Raising Presentation 1 https://app.sharelinktechnologies.com/announcement/asx/799ffde1268524e73b1f875e31347238
    Company Presentation
2024-06-03 09:28:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/95995a9bf07a9771fcdb4c8f820c1910
    Appendix 3B
2024-06-03 09:41:00 Immutep announces Ph 3 clinical trial collaboration with MSD 1 https://app.sharelinktechnologies.com/announcement/asx/fe0d6f7ca0f0591ba6df1946be184838
    Progress Report
2024-06-03 10:00:00 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/694b4b2625b95c2b2fd0acde10dec370
    Cleansing Notice
2024-06-05 09:11:00 Immutep completes institutional pro-rata offer & placement 1 https://app.sharelinktechnologies.com/announcement/asx/3ff9d50f9b9307e6bf606cccefcaf8f2
    Placement
    Non-Renounceable Issue
    Trading Halt Lifted
2024-06-07 12:53:00 Immutep retail entitlement offer booklet 0 https://app.sharelinktechnologies.com/announcement/asx/088affa7bb319d3fcff0726c9469c5ef
    Non-Renounceable Issue
    Disclosure Document
2024-06-07 13:02:00 Immutep letter to ineligible shareholders 0 https://app.sharelinktechnologies.com/announcement/asx/ee732df5d1565b5a4475b6225170d9a3
    Non-Renounceable Issue
    Letter to Shareholders
2024-06-12 09:30:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/818307d8f0d9ff4155f9c5be6b140e28
    Appendix 2A (Application for Quotation of Securities
2024-06-12 10:10:00 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/94830e3d827e21f8c3e4c39f6fa048b1
    Cleansing Notice
2024-06-14 08:19:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/9cc703c46fe703f60d717ab0ac181af2
    Change in substantial holding
2024-06-14 16:49:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/99ce5e7eff1927f5e3bdc9e29739693a
    Change in substantial holding
2024-06-18 12:16:00 Change in substantial holding from IFL 0 https://app.sharelinktechnologies.com/announcement/asx/1502c85a799a8961d3f3b9ccf8068cdd
    Change in substantial holding
2024-06-24 13:53:00 Immutep completes underwritten retail entitlement offer 1 https://app.sharelinktechnologies.com/announcement/asx/9babeb08b25b0f91ba73adb9a30b2b22
    Non-Renounceable Issue
    Issued Capital - Other
2024-06-25 08:16:00 Immutep signs agreement for anti-LAG-3 small molecules 0 https://app.sharelinktechnologies.com/announcement/asx/6d9a36a3f6f55e5f4bc8e20adab8ca98
    Progress Report
2024-06-25 08:59:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/b1de55ba56e3ebf02d8f12ced083102e
    Appendix 2A (Application for Quotation of Securities
2024-06-27 08:09:00 Positive topline results from ph2b in head & neck cancer 1 https://app.sharelinktechnologies.com/announcement/asx/01c5467c4a7bfb7ff699b32dd8adcd34
    Progress Report
2024-06-27 08:31:00 Webcast slides for new Efti clinical data in 1st line HNSCC 1 https://app.sharelinktechnologies.com/announcement/asx/b235b06f7415ed3bc29fec34729a0282
    Company Presentation
2024-07-03 08:33:00 Details for Immutep Webcast & ESMO Virtual Plenary Session 0 https://app.sharelinktechnologies.com/announcement/asx/85d22153acabcc162a340f52533bea2a
    Web Casts
2024-07-04 08:16:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/963ab987dafaac2b364ba94cb2aa75ca
    Change in substantial holding
2024-07-12 08:26:00 Webcast to discuss data presented at ESMO Plenary Session 1 https://app.sharelinktechnologies.com/announcement/asx/95e5ec28b393fecd37252210d1457b4b
    Company Presentation
    Web Casts
2024-07-12 08:26:00 Positive results in TACTI-003 for 1L HNSCC cohort B patients 1 https://app.sharelinktechnologies.com/announcement/asx/33fe812d78c0112b1d0aaf1dfc7178ee
    Progress Report
    Web Casts
2024-07-12 15:51:00 Becoming a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/30fa848918c13be9b89893ce8a1ff451
    Becoming a substantial holder
2024-07-17 08:48:00 Regulatory Clearance received for Phase 1 trial of IMP761 1 https://app.sharelinktechnologies.com/announcement/asx/9e31eb4c7a341fe1f7927a832d68b447
    Progress Report
2024-07-22 08:12:00 Successful Meeting with FDA on Phase III Design in NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/51086c5abb8fdd3bbf98f9457a22db26
    Progress Report
2024-07-26 16:43:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/a849231eebbaad415c2ef36c7ff64bbb
    Change in substantial holding
Powered by Share Link